OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.910
+0.160 (3.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $90.45 million as of December 20, 2024. Its market cap has decreased by -49.22% in one year.
Market Cap
90.45M
Enterprise Value
110.04M
1-Year Change
-49.22%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $90.45M, an increase of 164.46%. That is a compound annual growth rate of 16.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 90.40M | -65.20% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harvard Bioscience | 92.02M |
| Genenta Science | 91.63M |
| Zentek | 91.34M |
| Exagen | 90.83M |
| Adagene | 90.76M |
| Immunic | 90.08M |
| HilleVax | 89.72M |
| LENSAR | 89.43M |